The role of phosphodiesterase 4B in IL-8/LTB4-induced human neutrophil chemotaxis evaluated with a phosphodiesterase 4B inhibitor

被引:11
|
作者
Suzuki, Osamu [1 ,3 ]
Goto, Taiji [2 ]
Yoshino, Toshiharu [2 ]
Nakamura, Satoshi [3 ]
Maeda, Hiroaki [1 ]
机构
[1] Daiichi Sankyo Co Ltd, Biol Res Labs 3, Tokyo 1408710, Japan
[2] Daiichi Sankyo Co Ltd, Lead Discovery & Optimizat Res Labs 2, Tokyo 1408710, Japan
[3] Tokyo Inst Technol, Dept Bioengn, Atsugi, Kanagawa 2268501, Japan
关键词
phosphodiesterase; 4B; 4D; mononuclear cells; neutrophils; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; BLOOD MONONUCLEAR-CELLS; CYTOKINE PRODUCTION; EXPRESSION;
D O I
10.1515/acph-2015-0016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PDE4B was previously shown to be a dominant PDE4 subtype of neutrophils. However, its physiological role in the neutrophil function has not been evaluated. In this study, the inhibitory effects of a phosphodiesterase 4B (PDE4B)selective inhibitor (compound A) and subtype non-selective PDE4 inhibitors (roflumilast and cilomilast) were evaluated in human peripheral blood cells. Compound A, roflumilast and cilomilast in a similar manner inhibited TNF-alpha production by LPS-stimulated human mononuclear cells. However, the inhibitory effect of compound A on IL-8 or LTB4-induced chemotactic response of neutrophils was modest even at the highest concentration (10 mu mol L-1), whereas roflumilast and cilomilast inhibited IL-8 or LTB4-induced neutrophil chemotaxis. Our results suggest that PDE4B does not play an important role during the chemotactic response of human neutrophils.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 50 条
  • [1] Recent advances of Phosphodiesterase 4B in cancer
    Miao, Yu
    Peng, Li
    Chen, Zhaolin
    Hu, Ying
    Tao, Liangsong
    Yao, Yan
    Wu, Yincui
    Yang, Dashuai
    Xu, Tao
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2023, 27 (02) : 121 - 132
  • [2] Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    Azuma, Arata
    Cottin, Vincent
    Hesslinger, Christian
    Stowasser, Susanne
    Valenzuela, Claudia
    Wijsenbeek, Marlies S.
    Zoz, Donald F.
    Voss, Florian
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (23): : 2178 - 2187
  • [3] Phosphodiesterase 4B Inhibitor for Treatment of Idiopathic Pulmonary Fibrosis (IPF)
    Gillissen, A.
    ZEITSCHRIFT FUR PNEUMOLOGIE, 2022, 19 (06): : 387 - 388
  • [4] Phosphodiesterase 4B: Master Regulator of Brain Signaling
    Tibbo, Amy J.
    Baillie, George S.
    CELLS, 2020, 9 (05)
  • [5] LTB4-INDUCED IL-8 PRODUCTION IN CULTURED HUMAN BLOOD
    HEALY, CT
    MUNSTER, D
    SIMON, PL
    FASEB JOURNAL, 1992, 6 (04): : A1052 - A1052
  • [6] Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages
    Jin, SLC
    Lan, L
    Zoudilova, M
    Conti, M
    JOURNAL OF IMMUNOLOGY, 2005, 175 (03): : 1523 - 1531
  • [7] Phosphodiesterase-4B-Inhibitor zur Behandlung der idiopathischen Lungenfibrose (IPF)Phosphodiesterase 4B inhibitor for the treatment of idiopathic pulmonary fibrosis
    A. Gillissen
    Zeitschrift für Pneumologie, 2022, 19 (6) : 387 - 388
  • [8] Phosphodiesterase 4B plays a role in benzophenone-3-induced phototoxicity in normal human keratinocytes
    Kim, Hyoung-June
    Lee, Eunyoung
    Lee, Moonyoung
    Ahn, Sungjin
    Kim, Jungmin
    Liu, Jingjing
    Jin, Sun Hee
    Ha, Jaehyoun
    Bae, Il Hong
    Lee, Tae Ryong
    Noh, Minsoo
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2018, 338 : 174 - 181
  • [9] PHOSPHODIESTERASE 4B INHIBITION AS A THERAPEUTIC FOR TRAUMATIC BRAIN INJURY
    Wilson, N. M.
    Furones, C.
    Gurney, M. E.
    Dietrich, W. D.
    Atkins, C. M.
    JOURNAL OF NEUROTRAUMA, 2014, 31 (12) : A83 - A84
  • [10] Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL
    Kim, Sang-Woo
    Rai, Deepak
    McKeller, Morgan R.
    Aguiar, Ricardo C. T.
    BLOOD, 2009, 113 (24) : 6153 - 6160